BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $746,834 | +70.6% | 16,600 | +66.1% | 0.00% | +100.0% |
Q4 2022 | $437,837 | +77.3% | 9,994 | +316.2% | 0.00% | 0.0% |
Q3 2021 | $247,000 | -78.9% | 2,401 | -77.0% | 0.00% | -80.0% |
Q4 2020 | $1,173,000 | -68.8% | 10,460 | -83.7% | 0.01% | -82.8% |
Q1 2020 | $3,760,000 | -20.3% | 64,308 | +9.2% | 0.03% | -12.1% |
Q4 2019 | $4,719,000 | +158.0% | 58,900 | +136.5% | 0.03% | +106.2% |
Q3 2019 | $1,829,000 | +553.2% | 24,900 | +741.8% | 0.02% | +433.3% |
Q2 2019 | $280,000 | +2.9% | 2,958 | -13.0% | 0.00% | 0.0% |
Q1 2019 | $272,000 | -76.0% | 3,400 | -76.6% | 0.00% | -50.0% |
Q3 2018 | $1,132,000 | -17.9% | 14,500 | -33.2% | 0.01% | -25.0% |
Q2 2018 | $1,378,000 | +70.8% | 21,711 | +146.7% | 0.01% | +100.0% |
Q1 2018 | $807,000 | +85.1% | 8,800 | -19.3% | 0.00% | +33.3% |
Q1 2017 | $436,000 | +2080.0% | 10,900 | +990.0% | 0.00% | – |
Q2 2016 | $20,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |